FIREFLY (NASDAQ: AIFF) AND NEUROSIGMA PARTNER TO EXPAND ACCESS TO FIRST FDA-CLEARED, NON-DRUG TREATMENT FOR PEDIATRIC ADHD

Reuters · 2d ago

Please log in to view news